In this study, bioinformatics analysis revealed the expression of PSMD11 and PSMD14 in pancreatic ductal adenocarcinoma, which can be used as biomarkers for the prognosis of patients with PDAC. The gene discussed is PSMD14; the disease is pancreatic ductal adenocarcinoma.